Verition Fund Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-27,700
Closed -$252K – 3706
2024
Q4
$252K Sell
27,700
-3,400
-11% -$32.8K ﹤0.01% 2860
2024
Q3
$285K Hold
31,100
– – ﹤0.01% 2671
2024
Q2
$304K Buy
+31,100
New +$379K ﹤0.01% 2337
2022
Q1
– Sell
-2,300
Closed -$211K – 3025
2021
Q4
$211K Buy
+2,300
New +$275K ﹤0.01% 2226
2019
Q4
– Sell
-7,600
Closed -$515K – 1359
2019
Q3
$515K Buy
+7,600
New +$500K 0.01% 614

Other funds holding TDOC

Verition Fund Management's TDOC Position: Q2 2026 in Review

Verition Fund Management sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 35,379 shares — an estimated $193K sold.

Verition Fund Management first reported a position in TDOC in Q2 2019 and held it in 19 quarters. The position peaked at $2.53M in Q3 2019. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Verition Fund Management reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 35,379 Teladoc Health shares in Q2 2026, an estimated $193K.
  • Verition Fund Management first reported a position in Teladoc Health in Q2 2019 and held it in 19 quarters.
  • Verition Fund Management's Teladoc Health position peaked at $2.53M in Q3 2019.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.